Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic

Flora McErlane1, Michael W Beresford, Eileen M Baildam

  • 1Arthritis Research UK Epidemiology Unit, University of Manchester, , Manchester, UK.

Insights

Excluding erythrocyte sedimentation rate (ESR) from the Juvenile Arthritis Disease Activity Score (JADAS) improved its clinical applicability for most juvenile idiopathic arthritis (JIA) categories. The modified JADAS (JADAS3) showed excellent correlation with the original JADAS, supporting its use in routine clinical settings.

Area of Science:

  • Pediatric Rheumatology
  • Clinical Trial Methodology
  • Disease Activity Measurement

Background:

  • The Juvenile Arthritis Disease Activity Score (JADAS) is a key tool for assessing disease activity in juvenile idiopathic arthritis (JIA).
  • Its validity and feasibility across all JIA categories in routine clinical practice require further investigation.
  • The impact of excluding the erythrocyte sedimentation rate (ESR) on JADAS's correlation with disease markers is not fully understood.

Purpose of the Study:

  • To evaluate the validity and feasibility of JADAS in all JIA categories within a routine UK clinical setting.
  • To determine if excluding ESR (creating JADAS3) affects JADAS's correlation with single disease activity markers.

Main Methods:

  • JADAS and JADAS3 scores (versions 71, 27, and 10) were calculated at baseline for an inception cohort of children with JIA.
  • Correlation analyses were performed between JADAS, JADAS3, and individual disease activity/severity measures, stratified by JIA category.

Main Results:

  • JADAS and JADAS3 data were available for 352 and 551 children, respectively.
  • JADAS and JADAS3 scores varied significantly across JIA categories, with highest values in polyarticular disease patterns.
  • Excellent correlation was observed between JADAS and JADAS3 across all categories.
  • JADAS3-71 showed similar correlations to JADAS-71 with most indices, except ESR.

Conclusions:

  • This study provides evidence for the feasibility and construct validity of JADAS across all JIA categories in a UK routine clinical setting.
  • Excluding ESR from JADAS (JADAS3) appears to enhance its clinical applicability for most JIA categories.
  • JADAS3 demonstrates strong potential as a valid and practical measure of disease activity in JIA.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...